More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$204786793
EPS
0.01
P/E ratio
--
Price to sales
4.39
Dividend yield
--
Beta
1.103663
Previous close
$2.74
Today's open
$2.74
Day's range
$2.66 - $2.94
52 week range
$2.66 - $7.11
show more
CEO
Diem Nguyen
Employees
49
Headquarters
New York, NY
Exchange
NASDAQ Global Market
Shares outstanding
71855015
Issue type
Common Stock
Healthcare
Pharmaceuticals
SIGA Technologies, Inc. (SIGA) Q3 2026 Earnings Call Transcript
SIGA Technologies, Inc. (SIGA) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 10, 2026

What Siga Technologies (SIGA) Said on Its Q3 Earnings Call
Siga Technologies NASDAQ: SIGA said it continues to expect a new U.S. government procurement contract for its smallpox treatment TPOXX, although the timing remains uncertain after a slower-than-expected contracting process.
MarketBeat • Nov 10, 2026

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026
Awarded $15 Million Procurement Contract from Canadian Department of National Defence for Oral TPOXX in October Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2026. “While we continue to work with the U.S. Government toward a new TPOXX procurement contract, our international business remains an important part of our strategy,” stated Diem Nguyen, Chief Executive Officer.
GlobeNewsWire • Nov 9, 2026

SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.
NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies (NASDAQ: SIGA), a commercial stage pharmaceutical company, announced today that Dennis Hruby, Ph.D., Executive Vice President and Chief Scientific Officer, will retire effective today, concluding more than 30 years with the Company.
GlobeNewsWire • Nov 9, 2026

SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results
NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Monday, November 9, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.
GlobeNewsWire • Oct 29, 2026

SIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX®
Continues Canada's commitment to smallpox preparedness for the Canadian Armed Forces Continues Canada's commitment to smallpox preparedness for the Canadian Armed Forces
GlobeNewsWire • Oct 28, 2026

Siga Technologies Q2 Earnings Call Highlights
Siga Technologies NASDAQ: SIGA reported second-quarter product-related revenue of $38 million, driven primarily by deliveries of intravenous TPOXX to the U.S. Strategic National Stockpile and oral TPOXX sales to international customers. The company said the quarter reflected the variable timing of its government-focused procurement business after minimal product revenue in the first quarter.
MarketBeat • Aug 7, 2026

SIGA Technologies, Inc. (SIGA) Q2 2026 Earnings Call Transcript
SIGA Technologies, Inc. (SIGA) Q2 2026 Earnings Call Transcript
Seeking Alpha • Aug 7, 2026

SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, August 6, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.
GlobeNewsWire • Jul 30, 2026

Siga Technologies: Q2 Earnings Due, New TPOXX Orders A Must
Siga Technologies, Inc. remains a Hold, as revenue visibility hinges on BARDA contract renewal, with shares down ~40% since April. SIGA's sole commercial product, TPOXX, faces shrinking opportunities after losing EU approval for MPOX although mgmt is developing pediatric and PEP versions. Q1 2026 results showed stagnant revenues, widening losses, and reliance on a $26m BARDA delivery and $13m Asia Pacific contract.
Seeking Alpha • Jul 28, 2026

¹ Disclosures

Open an M1 investment account to buy and sell SIGA Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.